Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement

Author:
Actoverco
Date:
06 July 2024
HY6A3173

In a ceremony attended by specialists in endocrinology, neurology, and nutrition, Nexus, a subsidiary of the Actoverco Pharmaceutical Group, unveiled its new product, "Neurostyle."

Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company, announced that this supplement, produced in tablet form by Nexus specialists from the Actoverco Pharmaceutical Group, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections.

She stated that the ingredients used in the Neurostyle supplement include B vitamins, and emphasized that in addition to diabetic patients, individuals over 65, patients who have undergone gastrointestinal surgeries, and vegetarians are other groups that can benefit from the positive effects of this product.

She also mentioned that Nexus has distributed new products in the form of tablets, soft gels, and effervescent tablets, and plans to produce and market sachets and oral vials in the near future. She announced plans for a serious entry into the export market for these supplements.

Related Posts

M_HA1634

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

4R4A0991

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

WhatsApp Image 2024-09-23 at 10.46.39 AM

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress

Nahale Naraghi honors Pharmacist Day with a special message!

Nahaleh Naraqi honors Pharmacist Day with a special message!